Recruiting Neurofibromatosis Studies in Philadelphia
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Plexiform neurofibromas (PN) are known to cause significant morbidity in children with NF1. The recent FDA approval for selumetinib in children 2 years and older with inoperable symptomatic PN was bas...
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with pr...
About Neurofibromatosis Clinical Trials in Philadelphia
Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerve tissue. NF1 is the most common type, causing skin changes and bone deformities. Treatment includes monitoring, surgery for problematic tumors, and MEK inhibitors for plexiform neurofibromas.
There are currently 2 neurofibromatosis clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 220 participants. Research is being sponsored by University of Alabama at Birmingham, Healx Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neurofibromatosis Clinical Trials in Philadelphia — FAQ
Are there neurofibromatosis clinical trials in Philadelphia?
Yes, there are 2 neurofibromatosis clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What neurofibromatosis treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for neurofibromatosis.
Data updated March 2, 2026 from ClinicalTrials.gov